Abstract
Personalized medicine is a new interdisciplinary approach, focused on the development of patient-specific therapies, which considers the fact that every person has unique genetic and physiological characteristics. Modern bionanotechnological procedures are used in personalized medicine mostly to allow the identification of a person’s genetic profile, but also to develop new diagnostic and therapeutic tools and procedures.
Stem cells are a promising source of donor cells in regenerative medicine. In particular, induced pluripotent stem cells (iPSCs) represent a unique opportunity for self-therapies in a personalized approach. They can be derived from the patient’s somatic cells, such as fibroblasts, by the reprogramming process and successively differentiated in vitro into a required cell type, to be finally transplanted back into the patient. This autologous therapy eliminates the possibility of rejection and is ethically acceptable because it does not require manipulation of human embryos. Several disease-specific human iPSCs have been produced since their discovery, but also some serious problems have emerged. In this chapter we will describe how nanotechnological approaches, such as the use of nanoparticles (NPs) and nanostructured materials, can contribute in overcoming these obstacles to allow clinical applications of iPSCs.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Cao X, Deng W, Qu R, Yu Q, Li J, Yang Y, Cao Y, Gao X, Xu X, Yu J (2013) Non-viral co-delivery of the four Yamanaka factors for generation of human induced pluripotent stem cells via calcium phosphate nanocomposite particles. Adv Funct Mater 23:5403–5411. https://doi.org/10.1002/adfm.201203646
Chen G-Y, Pang DW-P, Hwang S-M, Tuan H-Y, Hu Y-C (2012a) A graphene-based platform for induced pluripotent stem cells culture and differentiation. Biomaterials 33:418–427. https://doi.org/10.1016/j.biomaterials.2011.09.071
Chen C-S, Soni S, Le C, Biasca M, Farr E, Chen EY-T, Chin W-C (2012b) Human stem cell neuronal differentiation on silk-carbon nanotube composite. Nanoscale Res Lett 7:126. https://doi.org/10.1186/1556-276X-7-126
Chen W, Tsai P-H, Hung Y, Chiou S-H, Mou C-Y (2013) Nonviral cell labeling and differentiation agent for induced pluripotent stem cells based on mesoporous silica nanoparticles. ACS Nano 7:8423–8440. https://doi.org/10.1021/nn401418n
Chin MH, Mason MJ, Xie W, Volinia S, Singer M, Peterson C, Ambartsumyan G, Aimiuwu O, Richter L, Zhang J, Khvorostov I, Ott V, Grunstein M, Lavon N, Benvenisty N, Croce CM, Clark AT, Baxter T, Pyle AD, Teitell MA, Pelegrini M, Plath K, Lowry WE (2009) Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell 5:111–123. https://doi.org/10.1016/j.stem.2009.06.008
Chowdhury F, Li Y, Poh Y-C, Yokohama-Tamaki T, Wang N, Tanaka TS (2010) Soft substrates promote homogeneous self-renewal of embryonic stem cells via downregulating cell-matrix tractions. PLoS One 5:e15655. https://doi.org/10.1371/journal.pone.0015655
Chueng S-TD, Yang L, Zhang Y, Lee K-B (2016) Multidimensional nanomaterials for the control of stem cell fate. Nano Converg 3:23. https://doi.org/10.1186/s40580-016-0083-9
De Los Angeles A, Daley GQ (2013) A chemical logic for reprogramming to pluripotency. Cell Res 23:1337–1338. https://doi.org/10.1038/cr.2013.119
Hanna JH, Saha K, Jaenisch R (2010) Somatic cell reprogramming and transitions between pluripotent states: facts, hypotheses, unresolved issues. Cell 143:508–525. https://doi.org/10.1016/j.cell.2010.10.008
Hou P, Li Y, Zhang X, Liu C, Guan J, Li H, Zhao T, Ye J, Yang W, Liu K, Ge J, Xu J, Zhang Q, Zhao Y, Deng H (2013) Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds. Science 341:651–654. https://doi.org/10.1126/science.1239278
Hu B-Y, Weick JP, Yu J, Ma L-X, Zhang X-Q, Thomson JA, Zhang S-C (2010) Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc Natl Acad Sci USA 107:4335–4340. https://doi.org/10.1073/pnas.0910012107
Jang S-F, Liu W-H, Song W-S, Chiang K-L, Ma H-I, Kao C-L, Chen M-T (2014) Nanomedicine-based neuroprotective strategies in patient specific-iPSC and personalized medicine. Int J Mol Sci 15:3904–3925. https://doi.org/10.3390/ijms15033904
Jozefczuk J, Drews K, Adjaye J (2012) Preparation of mouse embryonic fibroblast cells suitable for culturing human embryonic and induced pluripotent stem cells. J Vis Exp JoVE. https://doi.org/10.3791/3854
Kabiri M, Soleimani M, Shabani I, Futrega K, Ghaemi N, Ahvaz HH, Elahi E, Doran MR (2012) Neural differentiation of mouse embryonic stem cells on conductive nanofiber scaffolds. Biotechnol Lett 34:1357–1365. https://doi.org/10.1007/s10529-012-0889-4
Khan M, Narayanan K, Lu H, Choo Y, Du C, Wiradharma N, Yang Y-Y, Wan ACA (2013) Delivery of reprogramming factors into fibroblasts for generation of non-genetic induced pluripotent stem cells using a cationic bolaamphiphile as a non-viral vector. Biomaterials 34:5336–5343. https://doi.org/10.1016/j.biomaterials.2013.03.072
Kingham E, Oreffo ROC (2013) Embryonic and induced pluripotent stem cells: understanding, creating, and exploiting the nano-niche for regenerative medicine. ACS Nano 7:1867–1881. https://doi.org/10.1021/nn3037094
Lee CH, Kim J-H, Lee HJ, Jeon K, Lim H, Choi H y, Lee E-R, Park SH, Park J-Y, Hong S, Kim S, Cho S-G (2011) The generation of iPS cells using non-viral magnetic nanoparticle based transfection. Biomaterials 32:6683–6691. https://doi.org/10.1016/j.biomaterials.2011.05.070
Liu W-H, Chang Y-L, Lo W-L, Li H-Y, Hsiao C-W, Peng C-H, Chiou S-H, Ma H-I, Chen S-J (2015) Human induced pluripotent stem cell and nanotechnology-based therapeutics. Cell Transplant 24:2185–2195. https://doi.org/10.3727/096368914X685113
López-Fagundo C, Livi LL, Ramchal T, Darling EM, Hoffman-Kim D (2016) A biomimetic synthetic feeder layer supports the proliferation and self-renewal of mouse embryonic stem cells. Acta Biomater 39:55–64. https://doi.org/10.1016/j.actbio.2016.04.047
Nichols J, Smith A (2009) Naive and primed pluripotent states. Cell Stem Cell 4:487–492. https://doi.org/10.1016/j.stem.2009.05.015
Nur-E-Kamal A, Ahmed I, Kamal J, Schindler M, Meiners S (2006) Three-dimensional nanofibrillar surfaces promote self-renewal in mouse embryonic stem cells. Stem Cells Dayt Ohio 24:426–433. https://doi.org/10.1634/stemcells.2005-0170
Okita K, Ichisaka T, Yamanaka S (2007) Generation of germline-competent induced pluripotent stem cells. Nature 448:313–317. https://doi.org/10.1038/nature05934
Park SY, Park J, Sim SH, Sung MG, Kim KS, Hong BH, Hong S (2011) Enhanced differentiation of human neural stem cells into neurons on graphene. Adv Mater 23:H263–H267. https://doi.org/10.1002/adma.201101503
Park HY, Noh EH, Chung H-M, Kang M-J, Kim EY, Park SP (2012) Efficient generation of virus-free iPS cells using liposomal magnetofection. PLoS One 7:e45812. https://doi.org/10.1371/journal.pone.0045812
Riehemann K, Schneider SW, Luger TA, Godin B, Ferrari M, Fuchs H (2009) Nanomedicine – challenge and perspectives. Angew Chem Int Ed Engl 48:872–897. https://doi.org/10.1002/anie.200802585
Sohn Y-D, Somasuntharam I, Che P-L, Jayswal R, Murthy N, Davis ME, Yoon Y (2013) Induction of pluripotency in bone marrow mononuclear cells via polyketal nanoparticle-mediated delivery of mature microRNAs. Biomaterials 34:4235–4241. https://doi.org/10.1016/j.biomaterials.2013.02.005
Stadtfeld M, Hochedlinger K (2010) Induced pluripotency: history, mechanisms, and applications. Genes Dev 24:2239–2263. https://doi.org/10.1101/gad.1963910
Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663–676. https://doi.org/10.1016/j.cell.2006.07.024
Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861–872. https://doi.org/10.1016/j.cell.2007.11.019
Tammam S, Malak P, Correa D, Rothfuss O, Azzazy HME, Lamprecht A, Schulze-Osthoff K (2016) Nuclear delivery of recombinant OCT4 by chitosan nanoparticles for transgene-free generation of protein-induced pluripotent stem cells. Oncotarget 7:37728–37739. https://doi.org/10.18632/oncotarget.9276
Wei G, Ma PX (2008) Nanostructured biomaterials for regeneration. Adv Funct Mater 18:3566–3582. https://doi.org/10.1002/adfm.200800662
Wernig M, Zhao J-P, Pruszak J, Hedlund E, Fu D, Soldner F, Broccoli V, Constantine-Paton M, Isacson O, Jaenisch R (2008) Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson’s disease. Proc Natl Acad Sci 105:5856–5861. https://doi.org/10.1073/pnas.0801677105
Xie J, Willerth SM, Li X, Macewan MR, Rader A, Sakiyama-Elbert SE, Xia Y (2009) The differentiation of embryonic stem cells seeded on electrospun nanofibers into neural lineages. Biomaterials 30:354–362. https://doi.org/10.1016/j.biomaterials.2008.09.046
Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin II, Thomson JA (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318:1917–1920. https://doi.org/10.1126/science.1151526
Zhou H, Wu S, Joo JY, Zhu S, Han DW, Lin T, Trauger S, Bien G, Yao S, Zhu Y, Siuzdak G, Schöler HR, Duan L, Ding S (2009) Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 4:381–384. https://doi.org/10.1016/j.stem.2009.04.005
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Ban, J., Mladinić Pejatović, M. (2019). Nanotechnology Approaches for Autologous Stem Cell Manipulation in Personalized Regenerative Medicine. In: Bodiroga-Vukobrat, N., Rukavina, D., Pavelić, K., Sander, G.G. (eds) Personalized Medicine in Healthcare Systems. Europeanization and Globalization, vol 5. Springer, Cham. https://doi.org/10.1007/978-3-030-16465-2_4
Download citation
DOI: https://doi.org/10.1007/978-3-030-16465-2_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-16464-5
Online ISBN: 978-3-030-16465-2
eBook Packages: Law and CriminologyLaw and Criminology (R0)